A new coronavirus test from Becton Dickinson (NYSE:BDX) can deliver results about 15 minutes after a healthcare provider drops a person's blood sample in the test kit. The new test was developed by BioMedomics, a privately held company based in North Carolina that will also manufacture the point-of-care diagnostic.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,